15144 Long-term safety of apremilast treatment in patients with psoriasis or psoriatic arthritis: Pooled analysis for 260 weeks and beyond in the ESTEEM 1 and 2 and PALACE 1-4 phase 3 trials

2020 ◽  
Vol 83 (6) ◽  
pp. AB30
Author(s):  
Kristina Callis-Duffin ◽  
Andreas Pinter ◽  
Philip Mease ◽  
Paolo Gisondi ◽  
Paul Steven Yamauchi ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Pooled Analysis ◽  
Phase 3

scholarly journals Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies

2018 ◽  
Vol 5 (2) ◽  
pp. 567-582 ◽  
Author(s):  
Peter Nash ◽  
Laura C. Coates ◽  
Roy Fleischmann ◽  
Kim A. Papp ◽  
Juan Jesus Gomez-Reino ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Pooled Analysis ◽  
Phase 3 ◽  
Two Phase

THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab

2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 351.1-351
Author(s):  
L. Gossec ◽  
T.K. Kvien ◽  
P.G. Conaghan ◽  
M. Østergaard ◽  
J. Cañete ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Long Term Results ◽  
Phase 3 ◽  
Two Phase
Sign in / Sign up

Export Citation Format

Share Document